Funded startups/Lighthouse Pharmaceuticals, Inc.
LP

Lighthouse Pharmaceuticals, Inc.

SEC filing
Other · Novato, CA
Form D on EDGAR
Amount raised$15.2Msold at filing
Total offering$15.2M
Investors in the raise25count reported to the SEC
FiledMay 7, 2026first sale Apr 22, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Campbell MurrayDirector
Stephen DominyDirector
Casey LynchExecutive Officer, Director, Promoter

Executive officers, directors and promoters as listed on the Form D.